| PubMed |
Abstract |
RScore(About this table) |
| 1668105 |
Ruis NM, Rose JK, Valone FH: Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids. 1991 Dec;26(12):1060-4.
|
2(0,0,0,2) |
Details |
| 3053456 |
Valone SE, Rich EA, Wallis RS, Ellner JJ: Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun. 1988 Dec;56(12):3313-5.
|
2(0,0,0,2) |
Details |
| 8045673 |
Shames R, Ruis NM, Valone FH: Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3). Int J Immunopharmacol. 1994 Apr;16(4):335-43.
|
1(0,0,0,1) |
Details |
| 3141509 |
Valone FH, Epstein LB: Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. J Immunol. 1988 Dec 1;141(11):3945-50.
|
1(0,0,0,1) |
Details |
| 7545221 |
Valone FH, Kaufman PA, Guyre PM, Lewis LD, Memoli V, Deo Y, Graziano R, Fisher JL, Meyer L, Mrozek-Orlowski M, et al.: Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol. 1995 Sep;13(9):2281-92.
Elevated plasma levels of the monocyte products tumor necrosis factor alpha (TNF alpha), interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF), and neopterin were observed with maximal levels at doses > or = 7.0 mg/m2. |
1(0,0,0,1) |
Details |